IMF Publication - Understanding Pomalyst® (pomalidomide) capsules
IMF Publication - Understanding Pomalyst® (pomalidomide) capsules
Pomalyst® (pomalidomide) in combination with Dexamethasone was approved by the U.S. Food and Drug Administration (FDA) on February 8, 2013 for relapsed and refractory myeloma. You can also download a copy here: https://www.myeloma.org/resource-library/understanding-pomalystr-pomalidomide-capsules. |
-
Shipping Information
FREE SHIPPING for all tip cards and publications.
Shipping times typically take 7-14 business days. Orders totaling up to $49.99 will incur a shipping cost of $5; orders totaling $50 and up will incur a shipping cost of $10.
Currently, the IMF does not provide international shipping via our Shopify store. If you are planning to purchase IMF merchandise or to order free educational publications outside of the U.S. (including U.S. territories), please contact the IMF directly at the imf@myeloma.org or 1-818-487-7455.